| Old Articles: <Older 7581-7590 Newer> |
 |
The Motley Fool June 28, 2011 Eric Bleeker |
Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales?  |
The Motley Fool June 28, 2011 Eric Bleeker |
Where Is Teva Pharmaceuticals Finding Growth? Teva should see its sales continue to climb, especially in already booming international markets.  |
The Motley Fool June 27, 2011 Arundhati Parmar |
St. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.? St. Jude won't comment on whether the company plans to do a second clinical trial or whether it is confident it will win approval from the FDA without it.  |
The Motley Fool June 27, 2011 Brandon Glenn |
Cardinal Health Products Won't Be in Cleveland Medical Mart (or Any Other) Once an early high-profile supporter of the medical mart concept, drug distributor Cardinal Health has had an apparent change of opinion.  |
The Motley Fool June 27, 2011 Brian Orelli |
Double Ouch! 2 Monster Drops in 2 Trading Days Perhaps investors in Pain Therapeutics and DURECT would have rather been kept in the dark about these FDA rejections.  |
The Motley Fool June 27, 2011 Brian Orelli |
Data Galore, but Where's the FDA Approval? Presentations at the American Diabetes Association won't help with approvals.  |
The Motley Fool June 25, 2011 Jordan DiPietro |
Should You Buy and Hold AstraZeneca? AstraZeneca has a beta of 0.3, which is pretty low. Generally speaking, I like to see a beta below 1.2 for retirees, and AstraZeneca fits the bill.  |
Chemistry World June 24, 2011 Andrew Turley |
Pfizer to Keep 350 Jobs at Sandwich US drug giant Pfizer has said that it will keep 350 jobs at its site in Sandwich, UK.  |
Chemistry World June 24, 2011 Hepeng Jia |
Pharma pollution is out of control in China Active pharmaceutical ingredients pollution problems seem to continue even after the Chinese government increased efforts to reduce environmental pollution from drug makers.  |
The Motley Fool June 24, 2011 Brian Orelli |
Come on, Pfizer, Not Even a Little Hint? Remoxy is rejected, but why?  |
| <Older 7581-7590 Newer> Return to current articles. |